Table 3.
Authors | Study Design | Number of Study | Exposure Group | Exposure Type/Agent | * Evidence | Leukemia/Sub Type | † Prevalence | ‡ RR 95% CI |
---|---|---|---|---|---|---|---|---|
Sun et al., 2014 | Systematic review | 11 | Air pollution | Traffic density | Leukemia | 1.03, 0.98–1.09 | ||
Filippini et al., 2019 | Systematic review | 16 | Traffic density | Leukemia | 1.09, 1.00–1.20 | |||
9 | Traffic density | ALL | 1.05, 0.96–1.16 | |||||
3 | Traffic density <6 years | Little | ALL | NA | 1.02, 0.99–1.05 | |||
7 | Nitrogen Dioxide | Leukemia | 1.04, 0.90–1.19 | |||||
4 | Nitrogen Dioxide | ALL | 1.02, 0.89–1.18 | |||||
2 | Nitrogen Dioxide children <6 years | No | ALL | High | 1.10, 0.92–1.32 | |||
Filippini et al., 2015 | Systematic review | 4 | Chemicals | Proximity to petrol station | Leukemia | 1.83, 1.42–2.36 | ||
Filippini et al., 2019 | Systematic review | 8 | Benzene | Leukemia | 1.27, 1.03–1.56 | |||
7 | Benzene | ALL | 1.09, 0.88–1.36 | |||||
Benzene children < 6 years | Some | ALL | NA | 1.19, 1.00–1.40 | ||||
Schuz et al., 2007 | Pooled analysis | 4 | Electromagnetic fields | ELF-MF (10:00 p.m.–6:00 a.m.) 0.1 ≤ 0.2 µT | Leukemia | 1.11, 0.91–1.36 | ||
ELF-MF (10:00 p.m.–6:00 a.m.) 0.2 ≤ 0.4 µT | 1.37, 0.99–1.90 | |||||||
ELF-MF (10:00 p.m.–6:00 a.m.) ≥ 0.4 µT | 1.93, 1.11–3.35 | |||||||
ELF-MF 24-/48-h 0.1 ≤ 0.2 µT | 1.09, 0.89–1.32 | |||||||
ELF-MF 24-/48-h 0.2 ≤ 0.4 µT | 1.20, 0.89–1.06 | |||||||
ELF-MF24-/48-h ≥ 0.4 µT | 1.98, 1.18–3.35 | |||||||
Ahlbom et al., 2000 | Pooled analysis | 9 | ELF-MF 0.1 ≤ 0.2 µT | Leukemia | 1.08, 0.88–1.32 | |||
9 | ELF-MF 0.2 ≤ 0.4 µT | 1.12, 0.84–1.51 | ||||||
9 | ELF-MF ≥ 0.4 µT | 2.08, 1.30–3.33 | ||||||
7 | ELF-MF 0.1 ≤ 0.2 µT | 1.07, 0.81–1.41 | ||||||
7 | ELF-MF 0.2 ≤ 0.3 µT | 1.16, 0.69–1.93 | ||||||
7 | ELF-MF ≥ 0.3 µT | 1.44, 0.88–2.36 | ||||||
Greenland et al., 2000 | Pooled analysis | 12 | ELF-MF 0.1–0.2 µT—Wire Code Alone | Leukemia | 1.02, 0.81–1.29 | |||
ELF-MF 0.2–0.3 µT—Wire Code Alone | 1.01, 0.69–1.48 | |||||||
ELF-MF > 0.3 µT—Wire Code Alone | 1.38, 0.89–2.13 | |||||||
Zhao et al., 2014 | Systematic review | 7 | ELF-MF 0.1 ≤ 0.2 µT | ALL | 1.09, 0.85–1.39 | |||
ELF-MF 0.2 ≤ 0.4 µT | ALL | 1.04, 0.73–1.48 | ||||||
ELF-MF ≥ 0.4 µT | ALL | 2.43, 1.30–4.55 | ||||||
Greenland et al., 2000 | Pooled analysis | 12 | ELF-MF 2 µT | Leukemia | 1.08, 0.86–1.35 | |||
ELF-MF 0.2–0.3 µT | 1.10, 0.76–1.60 | |||||||
ELF-MF > 0.3 µT | 1.52, 0.99–2.33 | |||||||
Amoon et al., 2021 | Pooled analysis | 4 | ELF-MF ≥ 0.4 μT | Leukemia | 1.01, 0.61–1.66 | |||
ELF-MF 0.1 ≤ 0.2 μT | 1.10, 0.80–1.53 | |||||||
ELF-MF 0.2 ≤ 0.4 μT | 0.75, 0.46–1.21 | |||||||
Seomun et al., 2021 | Systematic review | 27 | ELF-MF 0.4µT | Some | Leukemia | Rare | 1.72, 1.25–2.35 | |
Liu et al., 2011 | Systematic review | 7 | Lifestyle, behaviour, infection | Paternal smoking | High | 1.24, 0.96–1.60 | ||
Chunxia et al., 2019 | Systematic review | 3 | Maternal smoking | Common | 0.84, 0.59–1.19 | |||
Rudant et al., 2015 | Pooled analysis | 11 | Lifestyle, behaviour, infection | Breastfeeding | ALL | 0.95, 0.89–1.02 | ||
Breastfeeding < 6 months | 1.01, 0.94–1.08 | |||||||
Breastfeeding ≥ 6 months | 0.86, 0.79–0.94 | |||||||
Breastfeeding | 0.95, 0.89–1.02 | |||||||
Breastfeeding < 6 months | 1.01, 0.94–1.08 | |||||||
Breastfeeding ≥ 6 months | 0.86, 0.79–0.94 | |||||||
Martin et al., 2005 | Systematic review | 17 | Breastfeeding | 0.91, 0.84–0.98 | ||||
Amitay et al., 2015 | Systematic review | 11 | Breastfeeding | 0.82, 0.73–0.93 | ||||
Kwan et al., 2004 | Systematic review | 14 | Breastfeeding | High | 0.76, 0.68–0.84 | |||
Urayama et al., 2010 | Systematic review | 9 | Lifestyle, behaviour, infection | Day-care attendance any time | 0.81, 0.70–0.94 | |||
11 | Day-care attendance at age ≤ 2 | 0.79, 0.65–0.95 | ||||||
Rudant et al., 2015 | Pooled analysis | 11 | Day-care centre attendance at <1 year of age | 0.77, 0.71–0.84 | ||||
11 | Day-care centre attendance at <1 year of age | Some(inverse) | High | 0.77, 0.71–0.84 | ||||
Orsi et al., 2018 | Pooled analysis | 13 | Lifestyle, behaviour, infection | Living on a farm | No | ALL | NA | 1.09, 0.86–1.36 |
Orsi et al., 2018 | Pooled analysis | 13 | Lifestyle, behaviour, infection | Contact with any pets | Some(inverse) | ALL | 0.90, 0.84–0.96 | |
Bailey et al., 2015b | Pooled analysis | 4 | Paint | Home paint-Any paint exposure | Some | B-lineage ALL | Rare | 1.22, 1.07–1.39 |
Bailey et al., 2015a | Pooled analysis | 5 | General-Professional pest control treatments | B-lineage ALL | Modest | 1.28,1.14–1.45 | ||
Van Maele-Fabry et al., 2019 | Systematic review | 8 | Pesticides | General | ALL | 1.42, 1.13–1.80 | ||
3 | General | 1.24, 0.90–1.70 | ||||||
3 | General-Indoor exposure | 1.19, 0.90–1.57 | ||||||
3 | General-Out door exposure | 1.27, 0.93–1.72 | ||||||
Turner et al., 2010 | Systematic review | 4 | General | ALL | 1.40, 0.90–2.16 | |||
Turner et al., 2010 | Systematic review | 3 | General-Indoor exposure | 1.56, 1.02–2.39 | ||||
Turner et al., 2010 | Systematic review | 4 | General-Outdoor exposure | 1.40, 1.05–1.87 | ||||
Chen et al., 2015 | Systematic review | 6 | General-Indoor | ALL | 1.59, 1.40–1.80 | |||
Chen et al., 2015 | Systematic review | 6 | General-Outdoor | 1.15, 0.95–1.38 | ||||
Chen et al., 2015 | Systematic review | 7 | General-Indoor pesticides-professional home | Some | Modest | 1.55, 1.38–1.75 | ||
Chen et al., 2015 | Systematic review | 7 | Home pesticide | 1.46, 1.29–1.65 | ||||
Chen et al., 2015 | Systematic review | 5 | Insecticides indoor | 1.59, 1.39–1.81 | ||||
Bailey et al., 2015a | Pooled analysis | 12 | Home pesticide | 1.35, 1.21, 1.52 | ||||
Bailey et al., 2015a | Pooled analysis | 5 | Household insecticide/miticide | Some | B-lineage ALL | Modest | 1.23, 1.12–1.34 | |
Vinson et al., 2011 | Systematic review | 20 | Pesticides | Herbicides | Leukemia | 1.26, 1.14–1.39 | ||
Vinson et al., 2011 | Systematic review | 45 | Insecticides | 1.17, 1.03–1.33 | ||||
Bailey et al., 2015a | Pooled analysis | 5 | Insecticide or fungicide | B-lineage ALL | 1.41, 1.26–1.59 | |||
Bailey et al., 2015a | Pooled analysis | 2 | Insect repellent (Personal) | 1.02, 0.86–1.20 | ||||
Bailey et al., 2015a | Pooled analysis | 5 | Herbicide | 1.34, 1.21–1.48 | ||||
Bailey et al., 2015a | Pooled analysis | 3 | Rodenticide | 1.32, 1.12–1.56 | ||||
Bailey et al., 2015a | Pooled analysis | 3 | Molluscicide | B-lineage ALL | 1.06, 0.87–1.30 | |||
Chen et al., 2015 | Systematic review | 9 | Insecticides-Outdoor | 1.11, 0.60–2.05 | ||||
Chen et al., 2015 | Systematic review | 5 | Herbicides Outdoor | 1.26, 1.10–1.44 | ||||
Van Maele-Fabry et al., 2019 | Systematic review | 3 | Insecticides | ALL | 1.19, 0.90–1.57 | |||
Van Maele-Fabry et al., 2019 | Systematic review | 3 | Herbicides | 1.24, 0.96–1.60 | ||||
Turner et al., 2010 | Systematic review | 3 | Insecticides | ALL | 1.35, 0.76–2.38 | |||
Turner et al., 2010 | Systematic review | 4 | Herbicides | Some | Modest | 0.85, 0.43–1.66 | ||
Bailey et al., 2015a | Pooled analysis | 6 | Pesticide used on pets | B-lineage ALL | NA | 1.15, 1.03–1.29 | ||
Baker and Hoel, 2007 | Systematic review | 6 | Radiation | Proximity to nuclear facilities Incidence All | 1.25, 1.13–1.38 | |||
6 | Radiation | Proximity to nuclear facilities Incidence < 16 km | 1.23, 1.07–1.40 | |||||
6 | Radiation | Proximity to nuclear facilities Mortality All | 1.06, 1.01–1.11 | |||||
6 | Radiation | Proximity to nuclear facilities Mortality < 16 km | Some | Leukemia | Modest | 1.23, 1.04–1.46 | ||
Lu et al., 2020 | Systematic review | 8 | Radiation | Domestic radon | 1.22, 1.01–1.42 | |||
2 | Radiation | Domestic radon | Conflicting | Leukemia | Moderate | 0.97, 0.81–1.15 | ||
Little et al., 2018 | Systematic review | 7 | Radiation | Low doses of ionising radiation 5–9.99 mSv | ALL | 2.41, 0.64–8.65 | ||
Radiation | Low doses of ionising radiation 10–19.99 mSv | 4.45, 1.50–14.08 | ||||||
Radiation | Low doses of ionising radiation 20–49.99 mSv | 4.20, 1.35–13.28 | ||||||
Radiation | Low doses of ionising radiation 50–100 mSv | 3.97, 0.97–14.15 | ||||||
Radiation | Low doses of ionising radiation RR at 100 mSv | Strong | Modest | 5.66, 1.35–19.71 |
* Evidence category reflects those in the same rows by exposure type; † source of prevalence is different from RR data; ‡ RR also includes OR.